Pharmacology and biological efficacy of a recombinant, humanized, single-chain antibody C5 complement inhibitor in patients undergoing coronary artery bypass graft surgery with cardiopulmonary bypass.
Fitch JC, Rollins S, Matis L, Alford B, Aranki S, Collard CD, Dewar M, Elefteriades J, Hines R, Kopf G, Kraker P, Li L, O'Hara R, Rinder C, Rinder H, Shaw R, Smith B, Stahl G, Shernan SK.
Fitch JC, et al. Among authors: shernan sk.
Circulation. 1999 Dec 21-28;100(25):2499-506. doi: 10.1161/01.cir.100.25.2499.
Circulation. 1999.
PMID: 10604887
Clinical Trial.